Your browser doesn't support javascript.
loading
Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real-life study.
Mastorino, Luca; Siliquini, Niccolò; Avallone, Gianluca; Zenone, Mattia; Ortoncelli, Michela; Quaglino, Pietro; Dapavo, Paolo; Ribero, Simone.
Afiliação
  • Mastorino L; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Siliquini N; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Avallone G; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Zenone M; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Ortoncelli M; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Quaglino P; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Dapavo P; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Ribero S; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
Dermatol Ther ; 35(10): e15670, 2022 10.
Article em En | MEDLINE | ID: mdl-35762118

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article